Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Psyched Wellness Ltd PSYCF


Primary Symbol: C.PSYC

Psyched Wellness Ltd. is a Canada-based health supplements company. The Company is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company creates organic, natural, and lab-tested mushroom products to promote health and wellness of people globally. The Company is in the process of developing a line of Amanita muscaria-derived water-based... see more

Recent & Breaking News (CSE:PSYC)

Gaining Traction, Gut Health Could be a $71.95 Billion Market Opportunity

Livemoney March 30, 2021

Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Newsfile March 30, 2021

Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

Livemoney March 26, 2021

More People Are Turning to Psychedelics to Treat Mental Health Issues

Livemoney March 18, 2021

Psyched Wellness (CSE:PSYC) submits a provisional patent application For AME-1

John Ballem  March 17, 2021

Psyched Wellness Submits a Provisional Patent Application For AME-1

Newsfile March 17, 2021

Psyched Wellness (CSE:PSYC) experiences changes to its Board of Directors

Brieanna McCutcheon  March 16, 2021

Psyched Wellness Brings New Business Experience to Board of Directors

Stockhouse Editorial March 16, 2021

Psyched Wellness Announces Changes to the Board of Directors

Newsfile March 15, 2021

Psyched Wellness (CSE:PSYC) provides update on pre-clinical trial of its Muscimol extract AME-1

John Ballem  March 2, 2021

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Newsfile March 2, 2021

Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

Newsfile February 17, 2021

Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

Newsfile February 4, 2021

Psyched Wellness to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference

Newsfile February 2, 2021

This New Psychedelics ETF Could Be One of the Hottest Ideas of 2021. Here's Why

Livemoney January 26, 2021

Psyched Wellness (CSE:PSYC) included in first Psychedelic Exchange Traded Fund

Isabella Zavarise January 26, 2021

Psyched Wellness Included in First Psychedelic Exchange Traded Fund

Newsfile January 26, 2021

Psyched Wellness to Present at Inaugural KCSA Psychedelics Investor Conference

Newsfile January 25, 2021

Re-Release: Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Newsfile January 25, 2021

Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Canada NewsWire January 22, 2021